| SCHEDULE OF LOSS PER SHARE |
For
the six months ended June 30, 2026 and 2025, loss per share of the Company is as follows:
SCHEDULE OF LOSS PER SHARE
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
Three Months Ended June 30 | | |
Six Months Ended June 30 | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Numerator: | |
| | | |
| | | |
| | | |
| | |
| Net Loss | |
$ | (252,573 | ) | |
$ | (401,403 | ) | |
$ | (738,456 | ) | |
$ | (841,811 | ) |
| Net loss per share attributable to common stockholders | |
$ | (252,573 | ) | |
$ | (401,403 | ) | |
$ | (738,456 | ) | |
$ | (841,811 | ) |
| Denominator: | |
| | | |
| | | |
| | | |
| | |
| Weighted average common shares outstanding, basic and diluted | |
| 16,072,267 | | |
| 16,072,267 | | |
| 16,072,267 | | |
| 14,407,244 | |
| Net loss per share attributable to common stockholders, basic and diluted | |
$ | (0.02 | ) | |
$ | (0.02 | ) | |
$ | (0.05 | ) | |
$ | (0.06 | ) |
|
| SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER SHARE |
The
Company excluded the following from the computation of diluted net loss per share attributable to common shareholders for the three months
ended June 30, 2026 and 2025 because including them would have had an anti-dilutive effect:
SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER SHARE
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
Three Months Ended June 30 | | |
Six Months Ended June 30 | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Shares issuable upon exercise of stock options | |
| 1,759,211 | | |
| 1,759,211 | | |
| 1,759,211 | | |
| 1,759,211 | |
| Warrants to purchase common stock outstanding | |
| 350,000 | | |
| 350,000 | | |
| 350,000 | | |
| 350,000 | |
| Total | |
| 2,109,211 | | |
| 2,109,211 | | |
| 2,109,211 | | |
| 2,109,211 | |
| Anti-dilutive shares | |
| 2,109,211 | | |
| 2,109,211 | | |
| 2,109,211 | | |
| 2,109,211 | |
|